mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.7 |
mRNA |
968 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.7 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.7 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.018 |
0.7 |